Deacetylase inhibition increases regulatory T cell function and decreases incidence and severity of collagen-induced arthritis. - Wikidata - wikimedia - TriplyDB

Deacetylase inhibition increases regulatory T cell function and decreases incidence and severity of collagen-induced arthritis.

Deacetylase inhibition increases regulatory T cell function and decreases incidence and severity of collagen-induced arthritis.

http://www.wikidata.org/entity/Q42571975

about

Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS)Epigenetic contributions in the development of rheumatoid arthritis Immune regulation by histone deacetylases: a focus on the alteration of FOXP3 activity HDAC inhibitors and immunotherapy; a double edged sword?Histone deacetylases as targets for treatment of multiple diseases FOXP3: genetic and epigenetic implications for autoimmunity Rapid temporal control of Foxp3 protein degradation by sirtuin-1.Ganglioside GM3 has an essential role in the pathogenesis and progression of rheumatoid arthritis.Helper T cell plasticity: impact of extrinsic and intrinsic signals on transcriptomes and epigenomes.Potential of epigenetic therapies in non-cancerous conditions.miR-182 and miR-10a are key regulators of Treg specialisation and stability during Schistosome and Leishmania-associated inflammation Histone deacetylase inhibitors for treating a spectrum of diseases not related to cancer Targeting inflammation in heart failure with histone deacetylase inhibitors.Histone/protein deacetylases control Foxp3 expression and the heat shock response of T-regulatory cells.Histone deacetylase inhibition alters dendritic cells to assume a tolerogenic phenotype and ameliorates arthritis in SKG mice Targeting Histone Deacetylases in Diseases: Where Are We?Histone/protein deacetylases and T-cell immune responses Loss of epigenetic modification driven by the Foxp3 transcription factor leads to regulatory T cell insufficiency.Molecular targets related to inflammation and insulin resistance and potential interventions Mammalian Sterile 20-like Kinase 1 (Mst1) Enhances the Stability of Forkhead Box P3 (Foxp3) and the Function of Regulatory T Cells by Modulating Foxp3 Acetylation.Valproic acid ameliorates coxsackievirus-B3-induced viral myocarditis by modulating Th17/Treg imbalance.Epigenetic mechanisms of regulation of Foxp3 expression.Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3+ regulatory T cells.Modulation of Treg function improves adenovirus vector-mediated gene expression in the airway.Lysosome-dependent p300/FOXP3 degradation and limits Treg cell functions and enhances targeted therapy against cancers.SAHA, an HDAC inhibitor, synergizes with tacrolimus to prevent murine cardiac allograft rejection.Treating arthritis by immunomodulation: is there a role for regulatory T cells?Histone acetyltransferase mediated regulation of FOXP3 acetylation and Treg function.Inhibition of histone deacetylases in inflammatory bowel diseases.HDAC inhibitors: modulating leukocyte differentiation, survival, proliferation and inflammation.Pathways towards an effective immunotherapy for Parkinson's disease Inflammation and adaptive immunity in Parkinson's disease.Histone deacetylase inhibitors as suppressors of bone destruction in inflammatory diseases.Perspectives on epigenetic-based immune intervention for rheumatic diseases.Treg cells in rheumatoid arthritis: an update.Epigenetics in rheumatoid arthritis: a primer for rheumatologists.Searching for the Achilles Heel of FOXP3 Epigenetic-based immune intervention for rheumatic diseases.Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay.The role of different subsets of regulatory T cells in immunopathogenesis of rheumatoid arthritis

P2860

Q24623371-362EB9F8-3A4C-46BC-BD57-6F28F0F16974 Q26849371-18698DC0-52BD-4666-B03A-2FE3B09D9EFE Q26851623-4FB5F6EC-701F-4458-81C3-049E8BA44525 Q26853102-1517D1A5-B85F-4829-9916-67BD48C31A48 Q27000389-97EA5B70-3079-4581-A5A1-FBC027701413 Q27003398-DA0980A2-08C9-4B2F-9153-4720E1BD7FE6 Q33886284-DE5351CC-F88F-4BE0-ACFF-85875E604F94 Q34328705-95CB7CAC-4444-4600-ADCA-8AE8F1E2A9C1 Q34356521-967607F2-C11A-4A3E-9104-CB754B5A5F43 Q34742578-DDA53CF9-62FD-43D3-8925-91AC44E5B488 Q34795455-46473DBF-2E71-4807-9347-7674E02DD6E4 Q35016934-76B66BD8-7675-4905-932D-52F3E29FE0B1 Q35016989-F6AE50DF-40F6-44B1-9212-308BE6BECF6C Q35300659-45A3C1EF-72E8-4205-ABF3-F83C610C5600 Q35557836-DE199467-AA42-4BBD-8C98-CDD7247C8F7E Q35821728-D3AB720A-5347-41BC-953B-6E9AE779274D Q35849307-B33E7811-F9CD-4A25-A7E0-3B2E1940A38C Q35992006-BDD15EDD-80AC-491D-A955-E1BD87C228DD Q36294297-B8401D7F-9DE7-4C88-B9E8-A569B78C4311 Q36407224-DC55CE26-C72E-4044-8DCB-2F2D07C30584 Q37326217-BB8EAD05-E5A9-4D05-95CB-B11FE8263848 Q37412329-357150C6-6266-4380-8749-60EE33F82ECE Q37621254-5E9D3A68-C26B-4A38-88E7-81BC28A770A7 Q37624300-58D2A4D5-A3F1-46F9-9306-80E99E337CBE Q37659437-FB240C09-7AEB-4EF3-B64E-BB2DB90D5489 Q37728062-20B7ACB9-5B86-4EBB-B69D-0AA8AE7D4989 Q37750140-8429406A-9AD9-4F52-A0DB-97FE5E358023 Q37792465-8C5DAC08-0F88-461D-B451-A259178A7946 Q37848684-D44687B7-238B-4C85-97AE-EF507F103920 Q37949185-2CAB82F8-D1AA-416F-A831-051E8BADCE22 Q37957125-63B5CEBF-B173-40AF-A7FC-C5E1EE3915E1 Q37982378-6558322F-9231-42B0-8210-C00244DF330C Q38008692-0076FFC9-0CA0-4027-B84F-9140873705DD Q38091122-3B4CC070-F64E-44D2-A01F-A9CD71D381C9 Q38124277-8C839115-AD4B-4CED-959D-6FBD4B626961 Q38145001-721BC8DE-E0D6-4185-BE9F-A57EC3592BCD Q38172210-A93E5FB2-AB8A-4843-AE0A-B415DA7FC558 Q38210478-EC297E10-3E73-4F1D-B65C-678D6070DA62 Q41042385-00B40B4E-241E-4CE0-B58C-1DB7BA66A000 Q41582338-834BAC70-4461-4814-BD95-4E193BBE94BA

P2860

Deacetylase inhibition increases regulatory T cell function and decreases incidence and severity of collagen-induced arthritis.

http://www.wikidata.org/entity/Q42571975

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Deacetylase inhibition increas ...... of collagen-induced arthritis.

@en

Deacetylase inhibition increas ...... of collagen-induced arthritis.

@nl

type

label

Deacetylase inhibition increas ...... of collagen-induced arthritis.

@en

Deacetylase inhibition increas ...... of collagen-induced arthritis.

@nl

prefLabel

Deacetylase inhibition increas ...... of collagen-induced arthritis.

@en

Deacetylase inhibition increas ...... of collagen-induced arthritis.

@nl

P1433

Q42571975-15239FBD-5E4E-47A7-8DFA-B833241F72F9

P1476

Q42571975-F0BAAA5D-574E-4F04-80B9-FE9E0D34DF43

P2093

Q42571975-056D4E3C-13E2-4806-A08B-EA9CA6F9F237

Q42571975-2F1AED92-9D4C-41F6-9117-6BDE0EA845AA

Q42571975-635FDAC0-940F-4A4C-A39A-25C5295509A6

Q42571975-6C90380C-94F4-4519-A814-02A4C881287D

Q42571975-8A1704F7-0438-4F4F-BEEF-2B60962A7821

Q42571975-CE1DFA3B-0BD6-4155-A7DA-A323EAB4CA65

Q42571975-EFB2011B-8BD6-45B0-8F14-3A858F74CCA0

P2860

Q42571975-00816A4C-BC25-4CD0-82A5-417FC0FC4758

Q42571975-02F4B190-CC29-4444-8AD9-6164B6BB87F6

Q42571975-05C17A99-DE41-47AD-A482-2C204D8F4C5D

Q42571975-1D591F66-1F5A-439E-A989-CDA99A199511

Q42571975-27707D31-1B0D-4895-B9C3-EC90C6C6DDAE

Q42571975-316AEEF1-88E4-4D67-ACBE-044DF637E1C8

Q42571975-3EBA7244-8C33-4832-9A20-9F6718FEB018

Q42571975-48ACE8D0-3407-4B4D-B4F4-7F372765E777

Q42571975-49B19F3E-1D00-4278-AB8E-1E70A3692F43

Q42571975-4B160EAD-9F36-45AB-9291-DCF5FD4D69E6

P304

Q42571975-9CE1FCF7-69C9-479F-8E06-A9739C0517FC

P31

Q42571975-0DC4263A-34B4-44EC-9EC1-207E92B1B02F

P356

Q42571975-59B2A7C2-6BE3-4EA8-895C-2AEA83ACFA62

P433

Q42571975-204AB751-387A-44F4-B204-ED45F4B53D6F

P478

Q42571975-280ACC4D-DF3E-48BA-A5F0-B982D024ABD0

P577

Q42571975-DF4FECFE-4116-4828-97B4-957A45820054

P5875

Q42571975-DE043D4C-F59D-4676-BF6A-1CB55CCB6E5A

P698

Q42571975-F5032EB2-3959-47A7-B008-A32380FA0CA7

P932

Q42571975-23A1240E-A220-4BA9-A6D5-786F4F608989

P356

J.YEXMP.2009.06.003

P1433

Experimental and Molecular Pathology

P1476

Deacetylase inhibition increas ...... of collagen-induced arthritis.

@en

P2093

Bin Li

http://www.w3.org/2001/XMLSchema#string

Geng Zhang

http://www.w3.org/2001/XMLSchema#string

Mark I Greene

http://www.w3.org/2001/XMLSchema#string

Narumi Furuuchi

http://www.w3.org/2001/XMLSchema#string

Sandra J Saouaf

http://www.w3.org/2001/XMLSchema#string

Wayne W Hancock

http://www.w3.org/2001/XMLSchema#string

Yuan Shen

http://www.w3.org/2001/XMLSchema#string

P2860

FOXP3 ensembles in T-cell regulation

FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression

The role of regulatory T cells in antigen-induced arthritis: aggravation of arthritis after depletion and amelioration after transfer of CD4+CD25+ T cells.

Control of regulatory T cell development by the transcription factor Foxp3

Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

An essential role for Scurfin in CD4+CD25+ T regulatory cells

Animal models of rheumatoid arthritis and their relevance to human disease.

Resetting the epigenetic histone code in the MRL-lpr/lpr mouse model of lupus by histone deacetylase inhibition.

Disabling TNF receptor signaling by induced conformational perturbation of tryptophan-107

P304

99-104

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YEXMP.2009.06.003

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

87

http://www.w3.org/2001/XMLSchema#string

P577

2009-07-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26647493

http://www.w3.org/2001/XMLSchema#string

P698

19577564

http://www.w3.org/2001/XMLSchema#string

P932

2753738

http://www.w3.org/2001/XMLSchema#string